Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Meta-Analysis
100%
Systematic Review
66%
Clostridium Botulinum Type A
66%
Hazard Ratio
56%
Subacute Care
50%
Glucagon-Like Peptide-1 Agonist
50%
Randomized Controlled Trial
40%
Ovarian Cancer
40%
Apoplexy
34%
Spinal Cord Injury
33%
Sodium Glucose Cotransporter 2 Inhibitor
33%
Meta-Regression
31%
Botulinum Toxin A
29%
Diseases
27%
Cohort Analysis
25%
Cross Sectional Study
25%
Patient with Type 2 Diabetes
25%
Maturity Onset Diabetes of the Young
25%
Adverse Event
24%
Retrospective Cohort Study
22%
Krukenberg Tumor
21%
Biological Marker
20%
Tetraplegia
20%
Pandemic
20%
Health Care Cost
19%
Coronavirinae
16%
Endometrium
16%
Rotator Cuff
16%
Cockayne Syndrome
16%
Nirmatrelvir
16%
Messenger RNA
16%
Menstrual Cycle
16%
Traumatic Spinal Cord Injury
16%
Hypersalivation
16%
Parkinson's Disease
16%
Pulmonary Rehabilitation
16%
Complex Regional Pain Syndrome
16%
Encephalitis
16%
medical rehabilitation
16%
Intensive Care Unit
16%
Immunotherapy
16%
Dextro Aspartic Acid
16%
Thrombocyte Rich Plasma
16%
Anti N Methyl D Aspartate Receptor Encephalitis
16%
Macrophage
16%
Scoliosis
16%
Uterine Cancer
16%
Continuous Performance Test
16%
Wechsler Memory Scale
16%
Rotator Cuff Rupture
16%
Mosaicism
16%
Trisomy 16
16%
Asplenia
16%
CADASIL Syndrome
16%
Clear Cell Carcinoma
16%
Spastic Diplegia
16%
Repetitive Transcranial Magnetic Stimulation
16%
Sarcopenia
16%
Omphalocele
16%
COVID-19
16%
Ritonavir
16%
Musculoskeletal Pain
16%
Drug Resistance
16%
Acetazolamide
16%
End Stage Renal Disease
16%
Multiple Sclerosis
16%
Hemodialysis
16%
Paroxysmal Dystonia
16%
Home Rehabilitation
16%
Berg Balance Scale
16%
Brachial Plexus Injury
16%
Distraction Osteogenesis
16%
Chlordane
16%
Microtubule Nucleation
16%
Lifespan
16%
Congestive Heart Failure
16%
Obstetrics
16%
Carpal Tunnel Syndrome
16%
Fibromyalgia
16%
Phosphotransferase
16%
Table Salt
16%
Breast Cancer Resistance Protein
16%
Omicron Coronavirus Variant
16%
Assistive Technology
16%
Life Expectancy
16%
Frailty
16%
Arthroplasty
16%
Sodium-Glucose Cotransporter 2 Inhibitors
16%
Osteoarthritis
16%
Subluxation
13%
Exercise Rehabilitation
12%
Physical Performance
12%
Electromyography
12%
Embryo Transfer
11%
Neoplasm
11%
Effect Size
11%
Parathion
11%
Walking Speed
10%
Activity of Daily Living Scale
10%
Neck Disability Index
9%
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
37%
Population-based Cohort Study
33%
Serous Ovarian Cancer
33%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
33%
Receptor Agonist
27%
A1 Receptor
27%
Glucagon-like
27%
Propensity Score Matching
20%
Type 2 Diabetic Patients
20%
Serotonin Transporter
16%
Midbrain
16%
Parkinson's Disease
16%
Punding
16%
Distribution Volume Ratio
16%
Major Depressive Disorder
16%
Heat Shock Protein 70 (HSP70)
16%
Post-acute Care
16%
Infrared Photos
16%
Photoenergy
16%
Spinal Cord Injury
16%
Omental Tumor
16%
Euthymic Patients
16%
CCL24
16%
Prognostic Ability
16%
Rehabilitation Exergames
16%
Dyssynergic Defecation
16%
Meta-analysis
16%
Crown Structure
16%
Cholesterol
16%
Nanoceria
16%
Urologic Chronic Pelvic Pain Syndrome
16%
Injury Analysis
16%
Plasma Parameters
16%
Pulmonary Rehabilitation
16%
Cardiovascular Rehabilitation
16%
Rotator Cuff Repair
16%
Repair Method
16%
Anti-N-methyl-D-aspartate Receptor Encephalitis
16%
Performance Scale
16%
Tetraplegia
16%
Economic Indicators
16%
Surface Electromyography (sEMG)
16%
Corelation
16%
Fuzzy Inference System
16%
Cerebral Palsy children
16%
Trisomy 16
16%
Non-mosaic
16%
Placental Abruption
16%
Asplenia Syndrome
16%
Uniparental
16%
Arteriopathy
16%
Subcortical Infarcts
16%
Ascertain Dementia 8
16%
Leukoencephalopathy Syndrome
16%
Early Cognitive Impairment
16%
Meta-analysis Regression
16%
Omphalocele
16%
Heroin Users
16%
Neurogenic Lower Urinary Tract Dysfunction (NLUTD)
16%
Environmental Barriers
16%
Musculoskeletal Pain
16%
Randomized Double-blind Placebo-controlled Study
16%
Upper Trapezius
16%
Matrix Implants
16%
Myofascial Pain Syndrome
16%
Fuzzy C-means
16%
Lidocaine Patch
16%
Fast Walking
16%
Acetazolamide
16%
Paroxysmal Dystonia
16%
Adrenocortical Carcinoma
16%
BI2536
16%
Systematic Meta-analysis
16%
Botulinum Toxin Injection
16%
Muscle Strength
16%
Wearable Assistive Device
16%
Strength Prediction
16%
Non-nutritive Sucking
16%
Glucagon-like peptide-1 Receptor (GLP-1R)
16%
Lateral Epicondylalgia
16%
Research Ethics Committees
16%
Therapeutic Effect
16%
Omicron Wave
16%
UCN-01
16%
Aptamer
16%
SARC-F
16%
Inference System
16%
Rotator Cuff Tear
16%
Thin Endometrium
16%
Restless Legs Syndrome
16%
Perceived Physical Environment
16%
Family History
16%
Autologous Platelet-rich Plasma
16%
Intergenerational Learning
16%
Ageing Mouse Model
16%
CILP2
16%
Arthroplasty
16%
Matched Cohort
16%
Osteoarthritis
16%
TriNetX
15%
Pharmacology, Toxicology and Pharmaceutical Science
Clostridium Botulinum Type A
83%
Ovary Cancer
56%
Randomized Controlled Trial
43%
Ovary Carcinoma
37%
Drug Resistance
33%
Epicondylitis
33%
Sarcopenia
33%
Glucagon Like Peptide 1 Receptor Agonist
33%
sodium glucose cotransporter-2 inhibitors
33%
Botulinum Toxin A
29%
Tumor Microenvironment
25%
Cohort Study
21%
Non Insulin Dependent Diabetes Mellitus
20%
Cerium Oxide Nanoparticle
20%
Retrospective Study
20%
Adverse Event
20%
Biological Marker
17%
Musculoskeletal Disease
16%
ABCG2
16%
Carpal Tunnel Syndrome
16%
Clear Cell Carcinoma
16%
Cockayne Syndrome
16%
Chlordane
16%
Messenger RNA
16%
Spinal Cord Injury
16%
Scoliosis
16%
Pandemic
16%
Rotator Cuff Rupture
16%
End Stage Renal Disease
16%
Hemodialysis
16%
Cerebral Palsy
16%
Phosphotransferase
16%
Lower Urinary Tract Symptom
16%
Table Salt
16%
Paroxysmal Dystonia
16%
Acetazolamide
16%
Adrenal Cortex Carcinoma
16%
4 (8 Cyclopentyl 7 Ethyl 5,6,7,8 Tetrahydro 5 Methyl 6 Oxo 2 Pteridinylamino) 3 Methoxy N (1 Methyl 4 Piperidinyl)benzamide
16%
Brachial Plexus Injury
16%
Pyroptosis
16%
Adrenal Cortex Tumor
16%
7 Hydroxystaurosporine
16%
Fibromyalgia
16%
Etoposide
16%
Neurologic Disease
16%
Musculoskeletal Pain
16%
Restless Legs Syndrome
16%
Hypersalivation
16%
Reactive Oxygen Metabolite
16%
Mouse Model
16%
Maturity Onset Diabetes of the Young
16%
Osteoarthritis
16%
Neoplasm
14%
Malignant Neoplasm
11%
Acne Vulgaris
8%
Phyllanthus Emblica
8%
Clinical Trial Results
8%
Dystonia
8%
Perfosfamide
7%
Recurrence Risk
5%
Subluxation
5%
Diseases
5%